NASDAQ:LONA
LeonaBio, Inc.
LeonaBio, Inc. reported net income of −$105.6M in fiscal 2025. The diluted share count rose 11.1%.Summary generated from LeonaBio, Inc.'s SEC filings. Latest annual report filed Mar 31, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−290.8%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+11.1%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating income | −64 | −104 | −125 | −101 | −102 |
| Net income | −55 | −96 | −118 | −97 | −106 |
| Free cash flow | −45 | −74 | −101 | −97 | n/a |
Recent filings
- 8-KOther events
Sep 22, 2026 - 8-KOther events
Aug 26, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 14, 2026 - 8-KResults of operations and financial condition
Aug 14, 2026 - 4Insider transaction report
Jul 10, 2026 - 4Insider transaction report
Jul 9, 2026 - 8-KResults of a shareholder vote
Jun 23, 2026 - DEF 14AProxy statement
May 11, 2026